Skip to content

Effect of Osteoporosis on Repair Outcomes of Severe Rotator Cuff Tears

Impact of Osteoporosis on the Efficacy of Supraspinatus Tendon Reconstruction for Irreparable Posterosuperior Massive Rotator Cuff Tears: A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118817
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Massive rotator cuff tear

Interventions

A Group (Normal Bone Density Group):None
B Group (Low Bone Mass Group):None
C Group (Osteoporosis Group):None

Sponsors

The First Affiliated Hospital of Army Medical University of the People's Liberation Army of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 50 and 75 years; 2. Preoperative MRI diagnosis of a massive posterosuperior rotator cuff tear (massive tear defined as: anteroposterior tear length >=5 cm on sagittal view, or involvement of two or more rotator cuff tendons), confirmed intraoperatively as irreparable; 3. Underwent arthroscopic supraspinatus tendon reconstruction using autologous iliotibial band; 4. Received dual-energy X-ray absorptiometry (DEXA) for bone mineral density within 1 week preoperatively, and underwent MRI of the affected shoulder preoperatively, at 6 months postoperatively, and at 12 months postoperatively; 5. Complete clinical data and minimum postoperative follow-up of 12 months.

Exclusion criteria

Exclusion criteria: 1. Concurrent shoulder fracture, dislocation, infection, or tumor; 2. History of prior ipsilateral shoulder surgery; 3. Autoimmune diseases severely affecting bone metabolism, such as rheumatoid arthritis, hyperparathyroidism, or ankylosing spondylitis; 4. Long-term use of glucocorticoids or other drugs affecting bone metabolism; 5. Dysfunction of vital organs including heart, liver, or kidney.

Design outcomes

Primary

MeasureTime frame
Constant score at 12 months postoperatively;

Secondary

MeasureTime frame
Constant score preoperatively and at 6 months postoperatively;Patient-reported pain VAS score;American Shoulder and Elbow Surgeons (ASES) score;Shoulder flexion, abduction, external rotation, and internal rotation range of motion;Graft healing status;

Countries

China

Contacts

Public ContactZhou Binghua

The First Affiliated Hospital of Army Medical University of the People's Liberation Army of China

yijian510868@hotmail.com+86 23 68765797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026